187 related articles for article (PubMed ID: 38391530)
1. A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and
Vintila BI; Arseniu AM; Morgovan C; Butuca A; Bîrluțiu V; Dobrea CM; Rus LL; Ghibu S; Bereanu AS; Arseniu R; Roxana Codru I; Sava M; Gabriela Gligor F
Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391530
[No Abstract] [Full Text] [Related]
2. A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated
Vintila BI; Arseniu AM; Morgovan C; Butuca A; Sava M; Bîrluțiu V; Rus LL; Ghibu S; Bereanu AS; Roxana Codru I; Gligor FG
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004450
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients infected with Clostridioides difficile at a Saudi Tertiary Academic Medical Center and assessment of antibiotic duration.
Alammari KM; Thabit AK
Gut Pathog; 2021 Feb; 13(1):10. PubMed ID: 33593421
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
Wombwell E; Patterson ME; Bransteitter B; Gillen LR
Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
[TBL] [Abstract][Full Text] [Related]
5. Characteristics, Risk Factors, and Prevalence of
Abukhalil AD; AbuKhdeir L; Hamed M; Al Shami N; Naseef HA; Aiesh BM; Sabateen A
Infect Drug Resist; 2021; 14():4681-4688. PubMed ID: 34785915
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
Johnson SW; Brown SV; Priest DH
Clin Infect Dis; 2020 Aug; 71(5):1133-1139. PubMed ID: 31560051
[TBL] [Abstract][Full Text] [Related]
7. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
Yu H; Flaster N; Casanello AL; Curcio D
Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
[TBL] [Abstract][Full Text] [Related]
8. Association Between Common Empiric Antibiotic Regimens and Clostridioides Difficile Infection in Pediatric Appendicitis.
Hu A; Tian Y; Huang L; Chaudhury A; Mathur R; Sullivan GA; Reiter A; Raval MV
J Pediatr Surg; 2024 Mar; 59(3):515-521. PubMed ID: 38092651
[TBL] [Abstract][Full Text] [Related]
9. The Effect of a Piperacillin/Tazobactam Shortage on Antimicrobial Prescribing and Clostridium difficile Risk in 88 US Medical Centers.
Gross AE; Johannes RS; Gupta V; Tabak YP; Srinivasan A; Bleasdale SC
Clin Infect Dis; 2017 Aug; 65(4):613-618. PubMed ID: 28444166
[TBL] [Abstract][Full Text] [Related]
10. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
11. Predictive Factors for the First Recurrence of
Marincu I; Bratosin F; Vidican I; Cerbu B; Turaiche M; Tirnea L; Timircan M
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32872476
[No Abstract] [Full Text] [Related]
12. Clinical Presentations, Predictive Factors, and Outcomes of Clostridioides difficile Infection among COVID-19 Hospitalized Patients—A Single Center Experience from the COVID Hospital of the University Clinical Center of Vojvodina, Serbia.
Kovačević N; Lendak D; Popović M; Plećaš Đuric A; Pete M; Petrić V; Sević S; Tomić S; Alargić J; Damjanov D; Kosjer D; Lekin M
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143939
[No Abstract] [Full Text] [Related]
13. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
Slimings C; Riley TV
J Antimicrob Chemother; 2021 Jun; 76(7):1676-1688. PubMed ID: 33787887
[TBL] [Abstract][Full Text] [Related]
14. Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network.
Rhea S; Jones K; Endres-Dighe S; Munoz B; Weber DJ; Hilscher R; MacFarquhar J; Sickbert-Bennett E; DiBiase L; Marx A; Rineer J; Lewis J; Bobashev G;
PLoS One; 2020; 15(6):e0234031. PubMed ID: 32525887
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
Schechner V; Fallach N; Braun T; Temkin E; Carmeli Y
J Antimicrob Chemother; 2021 Jul; 76(8):2182-2185. PubMed ID: 33969419
[TBL] [Abstract][Full Text] [Related]
16. Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
Lee JD; Heintz BH; Mosher HJ; Livorsi DJ; Egge JA; Lund BC
Clin Infect Dis; 2021 Oct; 73(7):e1579-e1586. PubMed ID: 33382398
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
18. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
19. A Single-Center, Retrospective Cohort Study Evaluating the Use of Probiotics for the Prevention of Hospital-Onset
Shah PJ; Halawi H; Kay J; Akogun A; Wise S; Aly S; Daoura N; Putney D
Hosp Pharm; 2023 Feb; 58(1):57-61. PubMed ID: 36644740
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics Associated With Clostridium difficile Infection.
Rafey A; Jahan S; Farooq U; Akhtar F; Irshad M; Nizamuddin S; Parveen A
Cureus; 2023 May; 15(5):e39029. PubMed ID: 37323360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
